Author:
Bader D,Kugelman A,Maor-Rogin N,Weinger-Abend M,Hershkowitz S,Tamir A,Lanir A,Attias D,Barak M
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,Pediatrics, Perinatology, and Child Health
Reference16 articles.
1. Meyer MP, Meyer JH, Commerford A, et al Recombinant human erythropoietin in the treatment of anemia of prematurity: results of a double-blind, placebo-controlled study Pediatrics 1994 93 918–923
2. Shannon KM, Keith JF, Mentzer WC, et al Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants Pediatrics 1995 95 1–8
3. Ohls RK, Osborne KA, Christensen RD Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial J Pediatr 1995 126 421–426
4. Maier RF, Obladen M, Scigalla P, et al The effect of epoietin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants N Engl J Med 1994 330 1173–1178
5. Bader D, Blondheim O, Jonas R, et al Decreased ferritin level, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity Acta Paediatr 1996 85 496–501
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献